Patents by Inventor Ryota Horibe

Ryota Horibe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor antigen peptide
    Patent number: 11028136
    Abstract: The object is to provide a tumor antigen peptide that is specifically presented on a cancer and a cancer stem cell, and a pharmaceutical composition, etc. that is useful for the prevention and/or treatment of a cancer and contains the above peptide as an active ingredient. The above object has been accomplished by providing a BORIS-derived partial peptide belonging to isoform A or C or subfamily 5 or 6, a polynucleotide encoding the peptide, a pharmaceutical composition containing the above as an active ingredient, and an agent for the prevention and/or treatment of a cancer, the agent containing the above as an active ingredient and inducing CTLs.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: June 8, 2021
    Assignees: Sapporo Medical University, Medical & Biological Laboratories Co., Ltd.
    Inventors: Toshihiko Torigoe, Eri Atsuyama, Hironori Otaka, Kazue Nakano, Dongliang Li, Shingo Toji, Takuya Asano, Ryota Horibe, Yoshihiko Hirohashi, Noriyuki Sato, Tsuyoshi Saito
  • TUMOR ANTIGEN PEPTIDE
    Publication number: 20170298109
    Abstract: The object is to provide a tumor antigen peptide that is specifically presented on a cancer and a cancer stem cell, and a pharmaceutical composition, etc. that is useful for the prevention and/or treatment of a cancer and contains the above peptide as an active ingredient. The above object has been accomplished by providing a BORIS-derived partial peptide belonging to isoform A or C or subfamily 5 or 6, a polynucleotide encoding the peptide, a pharmaceutical composition containing the above as an active ingredient, and an agent for the prevention and/or treatment of a cancer, the agent containing the above as an active ingredient and inducing CTLs.
    Type: Application
    Filed: September 24, 2015
    Publication date: October 19, 2017
    Applicants: Sapporo Medical University, Medical & Biological Laboratories Co., Ltd.
    Inventors: Toshihiko Torigoe, Eri Atsuyama, Hironori Otaka, Kazue Nakano, Dongliang Li, Shingo Toji, Takuya Asano, Ryota Horibe, Yoshihiko Hirohashi, Noriyuki Sato, Tsuyoshi Saito